Artigo de periodico

233rd ENMC International Workshop: Clinical Trial Readiness for Calpainopathies, Naarden, The Netherlands, 15–17 September 2017 (2018)

• Authors:
  • Lostal, William
  • Urtizberea, J. Andoni
  • Richard, Isabelle
  • Alonso-Jiménez, Alicia
  • Carlier, Robert-Yves
  • Carson, Vincent
  • Diaz-Manera, Jordi
  • Eymard, Bruno
  • Fardeau, Michel
  • Gourlay, Marie-Laurence
  • Guglieri, Michela
  • Hogrel, Jean-Yves
  • Kullmann, Bruno
  • Levy, Jennifer
  • Ono, Yasuko
  • Prigent, Hélène
  • Saenz, Amets
  • Semplicini, Claudio
  • Vainzof, Mariz
  • Vissing, John
  • Maggie, Walter
• Autor USP: VAINZOF, MARIZ - IB
• Unidade: IB
• DOI: 10.1016/j.nmd.2018.03.010
• Subjects: DISTROFIA MUSCULAR; MUTAÇÃO GENÉTICA; ENZIMAS; AMINOÁCIDOS; ENSAIO CLÍNICO
• Agências de fomento:
  • Financiado pela European Neuromuscular (ENMC)
  • Finaciado pela Association Française contre les Myopathies (France)
  • Financiado pela Deutsche Gesellschaft für Muskelkranke (Germany)
  • Financiado pela Muscular Dystrophy UK
  • Financiado pela Muskelsvindfonden (Denmark)
  • Financiado pela Prinses Beatrix Spierfonds (The Netherlands)
  • Financiado pela Schweizerische Stiftung für die Erforschung der Muskelkrankheiten (Switzerland)
  • Financiado pela Telethon Foundation (Italy)
  • Financiado pela Spierziekten Nederland (The Netherlands)
  • Financiado pela Associated members
  • Financiado pela Neuromuscular Association (Finland)
• Language: Inglês
• Imprenta:
  • Publisher place: London
  • Date published: 2018
• Source:
  • Título: Neuromuscular Disorders
  • ISSN: 0960-3966
  • Volume/Número/Paginação/Ano: v. 28, p. 540-549, 2018


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui acesso gratuito no site do editor (Bronze Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  LOSTAL, William et al. 233rd ENMC International Workshop: Clinical Trial Readiness for Calpainopathies, Naarden, The Netherlands, 15–17 September 2017. Neuromuscular Disorders, v. 28, p. 540-549, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.nmd.2018.03.010. Acesso em: 06 maio 2026.

• APA

  Lostal, W., Urtizberea, J. A., Richard, I., Alonso-Jiménez, A., Carlier, R. -Y., Carson, V., et al. (2018). 233rd ENMC International Workshop: Clinical Trial Readiness for Calpainopathies, Naarden, The Netherlands, 15–17 September 2017. Neuromuscular Disorders, 28, 540-549. doi:10.1016/j.nmd.2018.03.010

• NLM

  Lostal W, Urtizberea JA, Richard I, Alonso-Jiménez A, Carlier R-Y, Carson V, Diaz-Manera J, Eymard B, Fardeau M, Gourlay M-L, Guglieri M, Hogrel J-Y, Kullmann B, Levy J, Ono Y, Prigent H, Saenz A, Semplicini C, Vainzof M, Vissing J, Maggie W. 233rd ENMC International Workshop: Clinical Trial Readiness for Calpainopathies, Naarden, The Netherlands, 15–17 September 2017 [Internet]. Neuromuscular Disorders. 2018 ; 28 540-549.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.nmd.2018.03.010

• Vancouver

  Lostal W, Urtizberea JA, Richard I, Alonso-Jiménez A, Carlier R-Y, Carson V, Diaz-Manera J, Eymard B, Fardeau M, Gourlay M-L, Guglieri M, Hogrel J-Y, Kullmann B, Levy J, Ono Y, Prigent H, Saenz A, Semplicini C, Vainzof M, Vissing J, Maggie W. 233rd ENMC International Workshop: Clinical Trial Readiness for Calpainopathies, Naarden, The Netherlands, 15–17 September 2017 [Internet]. Neuromuscular Disorders. 2018 ; 28 540-549.[citado 2026 maio 06 ] Available from: https://doi.org/10.1016/j.nmd.2018.03.010

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Therapeutic potential of murine mesenchymal stem cells (MSC) from adipose tissue in the treatment of muscular dystrophy in the new double mutant mouse model for the genes Dystrophin and Large
• Estudo das enzimas glutamato desidrogenase, isocitrato desidrogenase, 'beta'-glucuronidase e isoenzima MB da creatino quinase no soro sanguineo de afetados por distrofias musculares progressivas
• Osteopontin expression during chronic and acute muscle injury
• Correction to: effects of low-intensity training on the brain and muscle in the congenital muscular dystrophy 1D model
• Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies
• Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date
• Striatum brain-derived neurotrophic factor levels are decreased in dystrophin-deficient mice
• Mitochondrial alterations in dynamin 2-related centronuclear myopathy
• Reduction of acethylcolinesterase activity in the brain of mdx mice
• Motor Chip: A comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders